February 12, 2009 - Researchers in The Netherlands say the standard of care of using intra-aortic balloon pumps (IABP) in patients with high-risk STEMI does not appear to help patients, according to a meta-analysis conducted by the Department of Cardiology, Academic Medical Center, University of Amsterdam.

February 12, 2009 - Endologix Inc. yesterday said a live-case demonstration of its new IntuiTrak Delivery System was featured at the International Congress XXII Endovascular Interventions conference in Scottsdale, AZ.

February 12, 2009 - Sanofi-aventis said yesterday the ATHENA trial was published in the New England Journal of Medicine, which shows its drug Multaq (dronedarone), in addition to standard therapy, significantly reduced the risk of first cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation (AF)/atrial flutter (AFL) or a recent history of these conditions.

February 12, 2009 - Osiris Therapeutics Inc. yesterday announced final two-year results for the company's trial evaluating Prochymal — a proprietary formulation of adult stem cells — for the treatment of acute myocardial infarction.

February 12, 2009- Transoma Medical’s Sleuth AT (Advanced Trending) cardiac monitoring system, the company’s second-generation wireless, automated implanted cardiac monitoring (ICM) device, has received FDA clearance.

Vascular Solutions’ Minnie support catheter is designed to provide superior guidewire support and exchange for complex interventions, with versions designed for use with 0.014-inch, 0.018-inch and 0.035-inch guidewires.

Atherotech Inc. is a cardio-diagnostic laboratory focusing on cardiovascular tests to better assess both risk and management and prevention of cardiovascular disease. The company’s patented VAP technology directly measures all lipoproteins and their subclasses.

The AgileTrac system uses real time location system (RTLS) technology to track the locations of people and devices critical to advancing patient flow through the hospital. The system integrates key events and data from other clinical IT systems in the hospital in addition to its collection of real time data that is automatically fed into the system to manage patient workflow.

Itamar Medical said its Endo-PAT2000 is a simple, noninvasive, inexpensive, office-based diagnostic test for endothelial function, the earliest clinically detectable stage of cardiovascular disease.

The POWERHEART AED G3 Pro features semi-automatic operation, manual override option and three-lead ECG monitoring to give hospitals the tools they need to be in complete control. The color ECG displays the victim’s heart rate, waveform, number of shocks delivered and the elapsed rescue time – exactly what resuscitation teams need to know, the company said.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now